DrugDashboards

Triamcinolone Acetonide

Triamcinolone Acetonide · TRIAMCINOLONE ACETONIDE 200 mg/5mL · Injection, Suspension · Intra-Articular; Intramuscular · Amneal Pharmaceuticals LLC

NDC 70121-1168-01 · 1 VIAL, MULTI-DOSE in 1 CARTON / 5 mL in 1 VIAL, MULTI-DOSE · ANDA · View full market →

The short version

22 companies supply this market — deep enough that no single failure threatens the supply. The generic price is up 28% over the past year, to $6.33 per mL. A shortage here was resolved within the past year — markets usually stay tight for a while after. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 4× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$6.33per MLinvoice-surveyed acquisition cost · Aug 19, 2026
  • Medicare Part B pays (ASP+6%)$0.9960per billing unit (10 MG)HCPCS J3301 · Jul 1, 2026
  • Part D plans paid (avg)$2.71per dosage unitgross, before rebates — matched by drug name · 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$2.50$5.00$7.50Jul 2023Sep 2026$6.33
26 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$43.35
Reported to Texas DSHS · 2026 annual filing · Amneal Pharmaceuticals LLC

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 10 MG
$0.996
HCPCS J3301 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$75,778
19,908 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

10● Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • sterile injectable+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for triamcinolone acetonide (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $10.46 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA207550
TE code
AB
Approval date
Dec 11, 2017
Patents / exclusivity
None on file

Shortage history

  • Shortage ended — Triesence, Injection, 40 mg/1 mL (NDC 82667-800-01)Sep 27, 2021 → Jul 31, 2026

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Triamcinolone Acetonide (Injection, Suspension)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 3, 2026
Amneal Pharmaceuticals LLCTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 3, 2026
Eugia US LLCTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 3, 2026
Teva Parenteral Medicines, Inc.TRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 3, 2026
A-S Medication SolutionsTRIAMCINOLONE ACETONIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Advanced Rx Pharmacy of Tennessee, LLCTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.TRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.TRIAMCINOLONE ACETONIDE 200 mg/5mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.TRIAMCINOLONE ACETONIDE 400 mg/10mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedTRIAMCINOLONE ACETONIDE 200 mg/5mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedTRIAMCINOLONE ACETONIDE 400 mg/10mLJul 15, 2026Sep 2, 2026
Asclemed Usa Inc.TRIAMCINOLONE ACETONIDE 200 mg/5mLJul 15, 2026Sep 2, 2026
Asclemed Usa Inc.TRIAMCINOLONE ACETONIDE 400 mg/10mLJul 15, 2026Sep 2, 2026
Bausch & Lomb IncorporatedTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories IncTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories IncTRIAMCINOLONE ACETONIDE 400 mg/10mLJul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories IncTRIAMCINOLONE ACETONIDE 200 mg/5mLJul 15, 2026Sep 2, 2026
Dr. Reddy's Labortories IncTRIAMCINOLONE ACETONIDE 10 mg/mLJul 15, 2026Sep 2, 2026
E.R. Squibb & Sons, L.L.C.TRIAMCINOLONE ACETONIDE 10 mg/mLJul 15, 2026Sep 2, 2026
E.R. Squibb & Sons, L.L.C.TRIAMCINOLONE ACETONIDE 80 mg/mLJul 15, 2026Sep 2, 2026
E.R. Squibb & Sons, L.L.C.TRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Harrow Eye, LLCTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.TRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Mylan Institutional LLCTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Mylan Institutional LLCTRIAMCINOLONE ACETONIDE 400 mg/10mLJul 15, 2026Sep 2, 2026
Mylan Institutional LLCTRIAMCINOLONE ACETONIDE 200 mg/5mLJul 15, 2026Sep 2, 2026
NorthStar Rx LLCTRIAMCINOLONE ACETONIDE 200 mg/5mLJul 15, 2026Sep 2, 2026
NorthStar Rx LLCTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
NorthStar Rx LLCTRIAMCINOLONE ACETONIDE 400 mg/10mLJul 15, 2026Sep 2, 2026
Novartis Pharmaceuticals CorporationTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Proficient Rx LPTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.TRIAMCINOLONE ACETONIDE 400 mg/10mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCTRIAMCINOLONE ACETONIDE 200 mg/5mLJul 15, 2026Aug 31, 2026
Asclemed USA, Inc.TRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Aug 31, 2026
Sportpharm LLCTRIAMCINOLONE ACETONIDE 400 mg/10mLJul 15, 2026Aug 31, 2026
Amneal Pharmaceuticals LLCTRIAMCINOLONE ACETONIDE 400 mg/10mLJul 15, 2026Aug 28, 2026
Sportpharm LLCTRIAMCINOLONE ACETONIDE 200 mg/5mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Triamcinolone Acetonide — NDC 70121-1168-01," retrieved September 3, 2026, https://drugdashboards.com/drug/70121116801.

Free to cite with attribution — see how the data is put together.